Amphastar Pharmaceuticals
- Market cap
- 1.09B
- P/E (TTM)i
- 15.11
- P/Bi
- 1.41
- EPSi
- 2.03
- Div yieldi
- 0.00%
- 52W posi
- 69%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Amphastar Pharmaceuticals closed at 25.54, down 1.43%. Its market capitalisation is about 1.09B, the #3194 most valuable US-listed company we track. Trading at a P/E of 15.11, the stock is 21% below its own five-year norm of 19.03. Across 4 analysts the consensus rating is Hold, with an average price target of 20.75 (-19%). The shares sit 69% of the way up their 52-week range of 16.65 to 29.52.
✦ StockVane Quant Insights how this is computed
- Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
- Valuation sits at the 24% percentile of its own 5-year range.
- Price momentum averages +13.0% across the trailing 3-month/1-year windows.
- Analyst consensus across 4 analysts is Hold.
- Recent price momentum is +13.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 11.7% of float.
- Analyst tilt is Hold.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 25.91
- Open
- 25.91
- Day range
- 25.29 - 26.17
- Avg price
- 25.63
- Volume
- 776.29K
- Turnover
- 19.90M
- Turnover ratei
- 2.48%
- Volume ratioi
- 1.66
- Amplitudei
- 3.42%
- 52-week rangei
- 16.65 - 29.52
Valuation
- P/Ei
- 12.58
- P/E (TTM)i
- 15.11
- P/Bi
- 1.41
- EPSi
- 2.03
- Book value / shi
- 18.06
- Net profit
- 86.35M
- Net assets
- 768.15M
Share structure
- Market cap
- 1.09B
- Float capi
- 799.22M
- Shares out
- 42.54M
- Float sharesi
- 31.29M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
13.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-759.88K net over the window
Short interest
- Shares short
- 4.99M
- % of floati
- 11.74%
- Days to coveri
- 10.75
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Amphastar Pharmaceuticals (AMPH)?
Amphastar Pharmaceuticals last traded at 25.54. The quote on this page refreshes every few seconds while US markets are open.
What is Amphastar Pharmaceuticals's market cap?
About 1.09B.
What is the P/E ratio of Amphastar Pharmaceuticals?
The trailing twelve-month P/E is 15.11, below its own 5-year average of 19.03 — in the middle of its historical range (44.69% percentile). See the Valuation tab for the full history.
Does Amphastar Pharmaceuticals pay a dividend?
Amphastar Pharmaceuticals does not currently pay a regular dividend.
Is Amphastar Pharmaceuticals a buy according to analysts?
The consensus of 4 analysts is a Hold rating, with an average 12-month price target of 20.75, which implies 18.8% downside from the current price. This is not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.